Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.
Elisabeth Buur StougaardPeter L KristensenUrd KielgastHenrik U AndersenYasmin HamidPeter H GædeEsben SøndergaardGry H DørflingerKaren K FjeldborgKlavs W HansenHenrik H ThomsenThuraya M J Al-ImarMichael RøderVikas S SridharDavid CherneyPeter RossingFrederik PerssonPublished in: Diabetes & vascular disease research (2022)
In 134 people with T1D treated with SGLT2i we found that none of the participants developed DKA during the treatment.